info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Point-of-Care Molecular Diagnostics Market Research Report Information by Product & Service (Assays & Kits, Instruments & Analyzers, and Software & Services), by Technology (RT-PCR, INAAT, and Others) By Application (Cancer, Infectious Diseases, Hematology, Endocrinology, and Others) By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030


ID: MRFR/HC/9964-HCR | 128 Pages | Author: Rahul Gotadki| July 2024

Point-of-Care Molecular Diagnostics Market Segmentation


Point-of-Care Molecular Diagnostics Product & Service Outlook (USD Billion, 2019-2030)




  • Assays & Kits




  • Instruments & Analyzers




  • Software & Services 




Point-of-Care Molecular Diagnostics Technology Outlook (USD Billion, 2019-2030)




  • RT-PCR




  • INAAT




  • Others 




Point-of-Care Molecular Diagnostics Application Outlook (USD Billion, 2019-2030)




  • Cancer




  • Infectious Diseases




  • Hematology




  • Endocrinology




  • Others 




Point-of-Care Molecular Diagnostics End User Outlook (USD Billion, 2019-2030)




  • Hospitals & Clinics




  • Diagnostic Centers




  • Others




Point-of-Care Molecular Diagnostics Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • North America Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • North America Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • North America Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • US Outlook (USD Billion, 2019-2030)




    • US Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • US Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • US Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • US Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Canada Outlook (USD Billion, 2019-2030)




    • Canada Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Canada Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Canada Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Canada Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Europe Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Europe Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Europe Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Germany Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Germany Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Germany Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • France Outlook (USD Billion, 2019-2030)




    • France Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • France Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • France Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • France Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • UK Outlook (USD Billion, 2019-2030)




    • UK Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • UK Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • UK Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • UK Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Italy Outlook (USD Billion, 2019-2030)




    • Italy Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Italy Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Italy Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Italy Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Spain Outlook (USD Billion, 2019-2030)




    • Spain Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Spain Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Spain Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Spain Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Rest of Europe Outlook (USD Billion, 2019-2030)




    • Rest of Europe Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Rest of Europe Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Rest of Europe Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Rest of Europe Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Asia-Pacific Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Asia-Pacific Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Asia-Pacific Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • China Outlook (USD Billion, 2019-2030)




    • China Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • China Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • China Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • China Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Japan Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Japan Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Japan Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • India Outlook (USD Billion, 2019-2030)




    • India Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • India Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • India Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • India Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • South Korea Outlook (USD Billion, 2019-2030)




    • South Korea Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • South Korea Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • South Korea Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • South Korea Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Australia Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Australia Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Australia Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Rest of Asia-Pacific Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Rest of Asia-Pacific Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Rest of Asia-Pacific Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Rest of the World Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Rest of the World Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Rest of the World Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Middle East Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Middle East Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Middle East Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Africa Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Africa Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Africa Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Point-of-Care Molecular Diagnostics by Product & Service




      • Assays & Kits




      • Instruments & Analyzers




      • Software & Services 






    • Latin America Point-of-Care Molecular Diagnostics by Technology 




      • RT-PCR




      • INAAT




      • Others






    • Latin America Point-of-Care Molecular Diagnostics by Application




      • Cancer




      • Infectious Diseases




      • Hematology




      • Endocrinology




      • Others 






    • Latin America Point-of-Care Molecular Diagnostics by End User




      • Hospitals & Clinics




      • Diagnostic Centers




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technology

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE

6.1. Overview

6.2. Assays & Kits

6.3. Instruments & Analyzers

6.4. Software & Services

7. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY

7.1. Overview

7.2. RT-PCR

7.3. INAAT

7.4. Others

8. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION

8.1. Overview

8.2. Cancer

8.3. Infectious Diseases

8.4. Hematology

8.5. Endocrinology

8.6. Others

9. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER

9.1. Overview

9.2. Hospitals & Clinics

9.3. Diagnostic Centers

9.4. Others

10. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY REGION

10.1. Overview

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. France

10.2.3. UK

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. Asia-Pacific

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Australia

10.3.6. Rest of Asia-Pacific

10.4. Rest of the World

10.4.1. Middle East

10.4.2. Africa

10.4.3. Latin America

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Point-of-Care Molecular Diagnostics Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Point-of-Care Molecular Diagnostics Market

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2022

11.8.2. Major Players R&D Expenditure. 2022

12. COMPANY PROFILES

12.1. Abbott Laboratories, Inc.

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. F. Hoffmann-La Roche Ltd

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. QIAGEN N.V.

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Becton, Dickinson and Company 

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Cepheid

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Altona Diagnostics GmbH

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Siemens Healthineers AG

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Thermo Fisher Scientific, Inc.

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Products Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. ELITechGroup

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Products Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Trinity Biotech plc

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Products Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SYNOPSIS, 2019–2030

TABLE 2 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECAST, 2019–2030 (USD MILLION)

TABLE 3 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 4 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 5 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 11 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 12 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 13 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 14 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 15 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 16 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 17 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 18 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 1 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 2 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 3 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 4 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 5 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 6 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 7 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 8 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 9 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 10 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 11 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 12 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 13 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 14 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 15 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 16 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 17 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 18 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 19 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 20 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 21 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 22 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 23 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 24 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 25 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 26 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 27 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 28 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 29 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 30 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 31 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 32 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 33 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 34 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 35 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 36 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 37 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 38 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 39 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 40 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 41 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 42 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 43 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 44 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 45 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 46 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 47 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 48 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 49 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 50 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 51 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 52 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 53 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 54 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 55 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 56 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 57 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 58 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 59 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 60 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 61 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 62 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 63 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 64 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 65 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 66 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 67 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 68 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

TABLE 69 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)

TABLE 70 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)

TABLE 71 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 72 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET

FIGURE 4 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY PRODUCT & SERVICE, 2022

FIGURE 5 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY TECHNOLOGY, 2022

FIGURE 6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY APPLICATION, 2022

FIGURE 7 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY END USER, 2022

FIGURE 8 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022

FIGURE 9 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022

FIGURE 10 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022

FIGURE 11 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022

FIGURE 12 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022

FIGURE 13 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS (%), 2022

FIGURE 14 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ABBOTT LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 16 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS

FIGURE 18 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 QIAGEN N.V.: SWOT ANALYSIS

FIGURE 20 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS

FIGURE 22 CEPHEID: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 CEPHEID: SWOT ANALYSIS

FIGURE 24 ALTONA DIAGNOSTICS GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 ALTONA DIAGNOSTICS GMBH: SWOT ANALYSIS

FIGURE 26 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS

FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS

FIGURE 30 ELITECHGROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ELITECHGROUP: SWOT ANALYSIS

FIGURE 32 TRINITY BIOTECH PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 TRINITY BIOTECH PLC: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.